General supervisor bioanalytical experience, including data review for multiple projects to assure high quality of reported data. Accomplished Senior Scientist with years of progressive excellence working with leading global pharmaceutical industries supporting the development and bringing to market a range of innovative pharmaceuticals across a spectrum of pathologies including Cardiovascular, CNS, Infectious Diseases and Oncology. Meticulous technician with a range of advanced laboratory skills practiced in varied methodologies, procedures and protocols supporting advanced experiments, research, trials and related documentation. Demonstrated abilities in the collection, management and related analysis of a broad range of experiments, research and pre-clinical and clinical data. Substantial knowledge of methodologies focused on protocol design and execution, experienced in coding using MedDRA, WHO Drug dictionary, and reporting using Individual Case Safety Report guidelines. Expertise in the analysis of diverse animal models relating to pharmacokinetic and pharmacodynamic relationships for preclinical drug discovery and pharmacovigilance signals detection and reporting of post marketing products. Demonstrated abilities in compliance assurances with all FDA, OSHA, ICH, GCP, EMA, GLP, and Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM) regulations, policies and practices.